🇺🇸 Chidamide in United States

32 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pyrexia — 6 reports (18.75%)
  2. Bone Marrow Failure — 5 reports (15.62%)
  3. Anaemia — 3 reports (9.38%)
  4. Diarrhoea — 3 reports (9.38%)
  5. Fatigue — 3 reports (9.38%)
  6. Nausea — 3 reports (9.38%)
  7. Pneumonitis — 3 reports (9.38%)
  8. Acute Kidney Injury — 2 reports (6.25%)
  9. Arthralgia — 2 reports (6.25%)
  10. Blood Uric Acid Increased — 2 reports (6.25%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Chidamide approved in United States?

Chidamide does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Chidamide in United States?

Sun Yat-sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.